Medable Inc. has announced the first stage of its European expansion plans with a new EMEA headquarters in Dublin. The regional headquarters will serve as a hub for expanded sales, customer success and software development in Europe. Medable’s European expansion is designed to enable greater engagement with hundreds of pharma, biotech and medical device companies across the UK, Germany, Switzerland, Spain, and Benelux.
Medable has an existing presence in Europe with roughly 60 employees and contractors currently based in the UK, Germany, Denmark, and various other locations in Central and Eastern Europe. The company intends to hire up to 50 positions in Dublin over the next three years, as part of its extensive growth across Europe in coming years.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.